Qiagen buys into bioinformatics; lowers 2013 guidance
This article was originally published in Clinica
Executive Summary
Highlighting the growing importance of bioinformatics, molecular diagnostic specialist Qiagen has bolstered its offering in the field, acquiring privately-held Californian firm Ingenuity Systems for $105 million in cash. Meanwhile, the Dutch firm has reported a less-than-stellar first fiscal quarter and trimmed its guidance for fiscal 2013 (see more details below).